Patent details

EP1210113 Title: COMBINED VACCINE COMPOSITIONS

Basic Information

Publication number:
EP1210113
PCT Application Number:
PCT/EP/2000/008784
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009676545
PCT Publication Number:
WO/2001/017551
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINED VACCINE COMPOSITIONS
French Title of Invention:
COMPOSITIONS DE VACCIN COMBINE
German Title of Invention:
KOMBINIERTE IMPFSTOFFZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
07/09/2000
Grant date:
29/03/2006
EP Publication Date:
29/03/2006
PCT Publication Date:
15/03/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/06/2002
EP B1 Publication Date:
29/03/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/09/2014
Expiration date:
07/09/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/09/2000
 
 

Name:
Glaxosmithkline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/05/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Wettendorff Martine, SmithKline Beecham Bio. s.a.
Address:
Belgium (BE)

Priority

Priority Number:
9921146
Priority Date:
07/09/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/295;
Filing date Document type Number of pages